Abstract
You have accessJournal of UrologyDiscussed Poster, Sunday, May 9, 2004, 8:00 am - 12:00 pm1 Apr 2004314: Gemcitabine Based Chemotherapy of Advanced Bladder Cancer in Elderly Patients-Investigations About the Influence of Age and Comorbidity on Therapy Caused Morbidity and Mortality Achim Elert, Carsten Ohlmann, Andres J. Schrader, Rainer Hofmann, and Axel Heidenreich Achim ElertAchim Elert More articles by this author , Carsten OhlmannCarsten Ohlmann More articles by this author , Andres J. SchraderAndres J. Schrader More articles by this author , Rainer HofmannRainer Hofmann More articles by this author , and Axel HeidenreichAxel Heidenreich More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)37576-1AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "314: Gemcitabine Based Chemotherapy of Advanced Bladder Cancer in Elderly Patients-Investigations About the Influence of Age and Comorbidity on Therapy Caused Morbidity and Mortality." The Journal of Urology, 171(4S), pp. 82–83 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 171Issue 4SApril 2004Page: 82-83 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Achim Elert More articles by this author Carsten Ohlmann More articles by this author Andres J. Schrader More articles by this author Rainer Hofmann More articles by this author Axel Heidenreich More articles by this author Expand All Advertisement PDF downloadLoading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.